Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02161679 |
|---|---|
| Brief Title: | Phase II Study of IMMU-132 Alone or in Combination With Carboplatin in Patients With Triple-Negative Breast Cancer |
| First Submitted : | June 10, 2014 |
| First Submitted that Met QC Criteria : | June 11, 2014 |
| First Posted : | June 12, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | August 12, 2021 |
| Last Update Posted : | August 19, 2021 |